ANI PHARMACEUTICALS INC · Drugmakers

ANIP

Low riskNext report: Around Nov 6 (est.)

View price ↗

The short version

A profitable company with growing sales.

Going well

Sales up 26% in the latest quarter vs a year ago
Profitable
Sales up 44% last year

Watch out for

Share count growing 9.3% a year

Money moves

Insiders sold $633K in the last 30 days, all through pre-planned sales
Institutions cut 1.3% from their holdings in the quarter ending June 2026 (171 bought, 112 sold)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$72.51-0.1% that day

Company value: $1.8B; Share price times all shares
Price vs profit (P/E): 15.7x; You pay about $16 for each $1 of yearly profit
Price vs sales: 1.8x; Company value is 1.8 times a year of sales
Cash vs value: 20%; Cash as a share of company value
Debt vs value: 17%; Debt as a share of company value

From ANIP's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$266.0M+26% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $978.4M, up 31% from the 12 months before. Over 5 years, sales grew about 34% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of ANIP. Starting points are the company's recent numbers.

Sales growth+30% a yearRecently: +31% a yearProfit margin11%Last 12 months: 11.0%P/E at the end16xToday: 15.7x. Many steady companies trade at 12x to 25xShare count change+10% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$3.6B

Profit in 5 years$400M

Price these guesses point to$162.55+124% vs $72.51 todayAbout +18% a year, before dividends

What today's price needs: with a 11% margin and a 16x P/E, sales would have to grow about 11% a year for 5 years just to match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

2/6Weak

PassReturn on equity 15%+Earns a lot on the money owners have in the business.16.5%
MissDebt under half of equityNot relying on borrowed money.0.57x equity
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.8.8%
MissProfitable every yearSteady profits, not one good year.5 of 10 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$171.4M
MissShare count not growingNot diluting owners. Falling means buybacks.+30.6% in 3 years

Revenue: $883.4M; +43.8% vs prior year
5-year growth: +33.5%/yr; revenue, per year
Total debt: $309.1M; 0.57x equity
Current ratio: 2.71x; short-term assets / bills due

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: gross margin 40%+. A checklist is a starting point for research, not a verdict.

Latest quarter

Quarter ended Jun 30, 2026

Reported Aug 7

Revenue: $266.0M; +25.9% YoY
EPS: $1.05; vs $0.36
Op. margin: 15.2%; +8.6 pts
Free cash flow: $53.6M
Share count: +7.9%; vs a year ago

Insider rating

Last 90 days

46Mixed

Pre-planned sales of $633K (weaker signal)

50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.

Weekly insider trend

13 weeks agoBoughtSoldThis week

Filing buzz

Last 7 days vs normal

0/ 100

This week: 0
Normal week: 1.7
vs normal: 0.0x

SEC filings of any kind. 50 means a normal week.

Institutional ownership

Steady-1.3%

Institutions cut 1.3% from their holdings. 171 bought, 112 sold.

Shares held by institutions23.0M

Sep '24Jun '26

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

+9.3%

Cash runwayAt last year's cash burn

Cash flow positive

Debt to equityLatest balance sheet: debt compared with what owners have

0.5x · $301.5M debt

Shares outstandingLatest reported

24M

Why low risk

Auditor change

Earnings reports

Last 12

Next reportAround Nov 6 (est.)Estimated from the same quarter last year

Results filedAug 7
Results filedMay 8
Results filedFeb 27
Results filedJan 12
Results filedNov 10, 2025

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

Auditor changeApr 7 · View filing ↗Watch

Insider trades

Open-market buys and sells, last 90 days

Bought$00 insiders

Sold$633K3 insiders, 3 pre-planned

Insider	Trade	Shares	Avg price	Value	Owns after	Date
Nikhil LalwaniPRESIDENT & CEO	Sell	5K	$71.89	$388K	334K	Oct 15Filing ↗
-1.6% of their holdings Pre-planned sale (10b5-1) Also Director Filed 1 day after
Meredith CookSR. VP, GENERAL COUNSEL & SEC.	Sell	500	$73.59	$37K	73K	Oct 13Filing ↗
-0.7% of their holdings Pre-planned sale (10b5-1) Filed same day
Stephen P. CareySVP & CFO	Sell	3K	$73.00	$208K	169K	Sep 29Filing ↗
-1.7% of their holdings Pre-planned sale (10b5-1) Filed 1 day after